Evidence map›Paper›PMID 28034373›Full record

Trial reportJACC. Heart failure2017

Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial.

Andrew P Ambrosy, Lukasz P Cerbin, Paul W Armstrong, Javed Butler, Adrian Coles, Adam D DeVore, Mark E Dunlap, Justin A Ezekowitz, G Michael Felker, Marat Fudim and 8 more

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JACC. Heart failure, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 65 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06244693 completednot on this mapstarted 2024, after this paper: background citation

Description and Analysis of Congestion During Hospitalization for Acute Decompensated Heart Failure

Typeobservational_patient_registrySponsorUniversity of ChileRan2024 to 2026Enrolled49ConditionsHeart Failure, CongestionArmsNo intervention
NCT07403058 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Endovascular Ablation Of The Right Greater Splanchnic Nerve In Subjects Having Heart Failure With Reduced Ejection Fraction: Randomized Controlled Feasibility Trial

TypeinterventionalSponsorAxon Therapies, Inc.Ran2026 to 2028Enrolled50ConditionsHeart Failure With Reduced Ejection Fraction (HFrEF)ArmsRight Greater Splanchnic Nerve (GSN) ablation, Sham Control
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024 · on this map
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Andrew P AmbrosyDivision of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Duke Clinical Research Institute, Durham, North Carolina.
Lukasz P CerbinDivision of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Paul W ArmstrongCanadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
Javed ButlerDivision of Cardiology, Stony Brook Heart Institute, Stony Brook, New York.
Adrian ColesDivision of Cardiology, Duke Clinical Research Institute, Durham, North Carolina.
Adam D DeVoreDivision of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Duke Clinical Research Institute, Durham, North Carolina.
Mark E DunlapDivision of Cardiology, MetroHealth Campus of Case Western Reserve University, Cleveland, Ohio.
Justin A EzekowitzCanadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
G Michael FelkerDivision of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Duke Clinical Research Institute, Durham, North Carolina.
Marat FudimDivision of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Stephen J GreeneDivision of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Adrian F HernandezDivision of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Duke Clinical Research Institute, Durham, North Carolina.
Christopher M O'ConnorDivision of Cardiology, Duke Clinical Research Institute, Durham, North Carolina.
Philip SchulteDivision of Cardiology, Duke Clinical Research Institute, Durham, North Carolina.
Randall C StarlingDivision of Cardiology, Cleveland Clinic, Cleveland, Ohio.
John R TeerlinkDivision of Cardiology, University of San Francisco, San Francisco, California.
Adriaan A VoorsDivision of Cardiology, University of Groningen, Groningen, the Netherlands.
Robert J MentzDivision of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Duke Clinical Research Institute, Durham, North Carolina. Electronic address: robert.mentz@dm.duke.edu.

Funding

Heart Failure Clinical Research Network Regional Clinical Center (U10)U10HL110312 · NHLBI · DUKE UNIVERSITY · PI FELKER, GARY M · 2012 to 2018
$3.5M
NHLBI NIH HHS U10 HL110312
6 · The paper itself

Abstract

objectivesThis study sought to examine the relationships between in-hospital and post-discharge body weight changes and outcomes among patients hospitalized for acute heart failure (AHF).

backgroundBody weight changes during and after hospitalization for AHF and the relationships with outcomes have not been well characterized.

methodsA post hoc analysis was performed of the ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure) trial, which enrolled patients admitted for AHF regardless of ejection fraction. In-hospital body weight change was defined as the difference between baseline and discharge/day 10, whereas post-discharge body weight change was defined as the difference between discharge/day 10 and day 30. Spearman rank correlations of weight change, urine output (UOP), and dyspnea relief as assessed by a 7-point Likert scale are described. Logistic and Cox proportional hazards regression was used to evaluate the relationship between weight change and outcomes.

resultsStudy participants with complete body weight data (n = 4,172) had a mean age of 65 ± 14 years, and 66% were male. Ischemic heart disease was reported in 60% of patients and the average ejection fraction was 30 ± 13%. The median change in body weight was -1.0 kg (interquartile range: -2.1 to 0.0 kg) at 24 h and -2.3 kg (interquartile range: -5.0 to -0.7 kg) by discharge/day 10. At hour 24, there was a weak correlation between change in body weight and UOP (r = -0.381), and minimal correlation between body weight change and dyspnea relief (r = -0.096). After risk adjustment, increasing body weight during hospitalization was associated with a 16% increase per kg in the likelihood of 30-day mortality or HF readmission for patients showing weight loss ≤1 kg or weight gain during hospitalization (odds ratio per kg increase 1.16, 95% confidence interval [CI]: 1.09 to 1.27; p < 0.001). Among the subset of patients experiencing >1-kg increase in body weight post-discharge, increasing body weight was associated with higher risk of 180-day mortality (hazard ratio per kg increase 1.16; 95% CI: 1.09 to 1.23; p < 0.001).

conclusionsA substantial number of patients experienced minimal weight loss or frank weight gain in the context of an AHF trial, and increasing body weight in this subset of patients was independently associated with a worse post-discharge prognosis.

Indexed as

HospitalizationWeight GainWeight LossAcute DiseaseAgedDyspneaFemaleHeart FailureHumansMaleMiddle AgedNatriuretic AgentsNatriuretic Peptide, BrainTreatment OutcomeUrineNatriuretic AgentsNatriuretic Peptide, Brainacute heart failurebody weightdyspneaurine output

Identifiers

PMID28034373
PMCPMC5218831

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.